I

InterCure Ltd
TASE:INCR

Watchlist Manager
InterCure Ltd
TASE:INCR
Watchlist
Price: 522.3 ILS 2.94% Market Closed
Market Cap: 251.2m ILS
Have any thoughts about
InterCure Ltd?
Write Note

Relative Value

The Relative Value of one INCR stock under the Base Case scenario is 1 474.51 ILS. Compared to the current market price of 522.3 ILS, InterCure Ltd is Undervalued by 65%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

INCR Relative Value
Base Case
1 474.51 ILS
Undervaluation 65%
Relative Value
Price
I
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
65
Median 3Y
1.3
Median 5Y
3.8
Industry
2.6
Forward
0.9
vs History
vs Industry
20
Median 3Y
13.4
Median 5Y
11.3
Industry
23
Forward
-134.5
vs History
vs Industry
46
Median 3Y
-4.4
Median 5Y
-6.3
Industry
17.8
vs History
vs Industry
24
Median 3Y
4
Median 5Y
-2.7
Industry
25.4
vs History
85
vs Industry
63
Median 3Y
1
Median 5Y
2.1
Industry
2.2
vs History
85
vs Industry
66
Median 3Y
1.3
Median 5Y
3.2
Industry
2.8
Forward
0.9
vs History
79
vs Industry
49
Median 3Y
3.6
Median 5Y
7.5
Industry
5.4
vs History
57
vs Industry
35
Median 3Y
8.1
Median 5Y
7.1
Industry
13.7
Forward
10.3
vs History
52
vs Industry
33
Median 3Y
11.1
Median 5Y
9.9
Industry
17.2
Forward
19.6
vs History
vs Industry
46
Median 3Y
-4.5
Median 5Y
-6.3
Industry
16.5
vs History
vs Industry
31
Median 3Y
-6.9
Median 5Y
-13.3
Industry
19.3
vs History
85
vs Industry
65
Median 3Y
0.8
Median 5Y
2
Industry
2

Multiples Across Competitors

INCR Competitors Multiples
InterCure Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
InterCure Ltd
TASE:INCR
251.2m ILS 0.7 -4.1 5.3 7.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
771.1B USD 18.9 92.1 49.5 55.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35.3 24.5 28
US
Johnson & Johnson
NYSE:JNJ
368.9B USD 4.2 25.1 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
249.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
209.8B CHF 3.6 18.2 10.3 12.2
CH
Novartis AG
SIX:NOVN
179.9B CHF 4.2 12.6 10 14.8
UK
AstraZeneca PLC
LSE:AZN
157.3B GBP 4.1 31 169.2 253.5
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
IL
I
InterCure Ltd
TASE:INCR
Average P/E: 33.6
Negative Multiple: -4.1
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
92.1
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35.3
86%
US
Johnson & Johnson
NYSE:JNJ
25.1
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top